Home - Products - GPCR/G Protein - 5-HT Receptor - (Iso)-Landipirdine

(Iso)-Landipirdine

CAS No. 1000308-09-7

(Iso)-Landipirdine( —— )

Catalog No. M34308 CAS No. 1000308-09-7

(Iso)-Landipirdine((Iso)-RO5025181) is a selective and potent 5-HT6R antagonist.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
2MG	296	Get Quote
5MG	459	Get Quote
10MG	657	Get Quote
25MG	994	Get Quote
50MG	1371	Get Quote
500MG	Get Quote	Get Quote
1G	Get Quote	Get Quote

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

(Iso)-Landipirdine
Note

Research use only, not for human use.
Brief Description

(Iso)-Landipirdine((Iso)-RO5025181) is a selective and potent 5-HT6R antagonist.
Description

(Iso)-Landipirdine((Iso)-RO5025181) is a selective and potent 5-HT6R antagonist. (Iso)-Landipirdine has a significant effect on the hERG pharmacophore and can be used to study neurological disorders in the Alzheimer's disease class.
In Vitro

——
In Vivo

——
Synonyms

——
Pathway

GPCR/G Protein
Target

5-HT Receptor
Recptor

5-HT Receptor
Research Area

——
Indication

——

Chemical Information

CAS Number

1000308-09-7
Formula Weight

362.42
Molecular Formula

C18H19FN2O3S
Purity

>98% (HPLC)
Solubility

——
SMILES

C(NC(N)=O)[C@@H]1C=2C(=CC(S(=O)(=O)C3=CC(F)=CC=C3)=CC2)CCC1
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

Velusetrag hydrochlo...

Velusetrag (TD-5108) is a potent, selective and oral 5-HT4 receptor agonist with pKi of 7.7, shows >500-fold selectivity over other 5-HT receptors.
LY266097 hydrochlori...

LY266097 hydrochloride (LY 266097 hydrochloride) is an antagonist of 5-HT2 with pKis of 7.7, 9.8, and 7.6 for human 5-HT2A, 5-HT2B, and 5-HT2C and can be used in studies about depression.
PF-05212377

PF-05212377 (SAM-760, PF 5212377) is a potent and selective 5-HT6 receptor antagonist with potential therapy for the symptomatic treatment of mild to moderate Alzheimer's disease.

Sign In Join Free